Pedro Machado Medeiros de Albuquerque

Pedro Machado Medeiros de Albuquerque

Auto-generated profile, based on publicly available information

Pedro Machado Medeiros de Albuquerque

Universidade Federal de Pelotas, Brasil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2021 in Biotechnology Letters
Verified
Journal Article
Closed access
PDF file
RPRenan E. A. Piraine
Renan E. A. Piraine
VGVitória Sequeira Gonçalves
Vitória Sequeira Gonçalves
AJAlceu Gonçalves dos Santos Junior
Alceu Gonçalves dos Santos Junior
RCRodrigo Cunha
Rodrigo Cunha
PAPedro Machado Medeiros de Albuquerque
Pedro Machado Medeiros de Albuquerque
FLFabio Leite
Fabio Leite

1 May 2020 in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Verified
Journal Article
Open access
PDF file
PRP.R.C. Rodrigues
P.R.C. Rodrigues
RCRodrigo Cunha
Rodrigo Cunha
FSF.D.S. Santos
F.D.S. Santos
VGV.S. Gonçalves
V.S. Gonçalves
PAP.M.M. Albuquerque
P.M.M. Albuquerque
FLFabio Leite
Fabio Leite
RESUMO O herpesvírus equídeo 1 (EHV-1) apresenta distribuição mundial e causa graves prejuízos à equideocultura. É agente de surtos de doença respiratória, reprodutiva e neurológica, em equídeos jovens e adultos. A glicoproteína D (gD) do envelope viral é essencial para ligação e penetração em células permissivas e direcionamento do sistema imunológico do hospedeiro, induz respostas imunes humorais e celulares, sendo um antígeno apropriado para ser utilizado em vacinas e imunodiagnóstico. O objetivo deste trabalho foi expressar e caracterizar a gD do EHV-1 em Pichia pastoris para posterior utilização como antígeno em técnicas de imunodiagnóstico e formulação de vacinas recombinantes. Uma sequência de DNA que codifica uma forma truncada da gDEHV-1 foi clonada no vetor pPICZαA de expressão em P. pastoris. Obteve-se uma proteína de ~41 kDa, como esperado. A proteína apresentou glicosilação entre 4 kDa e 16 kDa, demonstrada por deglicosilação enzimática. A proteína recombinante foi caracterizada antigenicamente e imunogenicamente por Western blot, utilizando-se anticorpos policlonais equinos anti-EHV-1, e por ELISA indireto em modelo murino, demonstrando que a gD recombinante manteve epítopos similares aos da proteína nativa. Esses resultados sugerem que a gDEHV-1 é um antígeno promissor para uso como imunobiológico no controle do EHV-1.

1 January 2021 in Brazilian Archives of Biology and Technology
Verified
Journal Article
Open access
LELívia Budziarek Eslabão
Lívia Budziarek Eslabão
NCNeida Conrad
Neida Conrad
PAPedro Machado Medeiros de Albuquerque
Pedro Machado Medeiros de Albuquerque
RCRodrigo Cunha
Rodrigo Cunha
AJAntonio Sergio Varela Junior
Antonio Sergio Varela Junior
FLFabio Leite
Fabio Leite

1 January 2026 in Journal of Tropical Medicine
Verified
Journal Article
Open access
PDF file
WZWillian Cardoso Ferreira Zorrer
Willian Cardoso Ferreira Zorrer
EREstefani Rinaldi
Estefani Rinaldi
BFBibiana Rodrigues de Freitas
Bibiana Rodrigues de Freitas
PAPedro Machado Medeiros de Albuquerque
Pedro Machado Medeiros de Albuquerque
NRNatalia Machado Rahal
Natalia Machado Rahal
FBFabio Raphael Pascotti Bruhn
Fabio Raphael Pascotti Bruhn
Opportunistic infections caused by the protozoa Cryptosporidium spp. and Cystoisospora belli represent a challenge for public health, particularly in immunocompromised patients. In Brazil, a country with continental dimensions and socioeconomic diversity, the epidemiology of these intestinal coccidioses is complex and often underestimated. This review article aims to consolidate current knowledge on Cryptosporidium and Cystoisospora infections in immunocompromised individuals within the Brazilian context, addressing clinical manifestations, epidemiology, risk factors, diagnostic methods, treatment options, prevention and control strategies, and challenges related to underreporting. A thorough understanding of these aspects is crucial for improving health policies, optimizing clinical management, and reducing the morbidity and mortality associated with these parasitic diseases.

1 January 2026 in Brazilian Archives of Biology and Technology
Verified
Journal Article
Open access
RFRenata Nobre da Fonseca
Renata Nobre da Fonseca
NCNeida Conrad
Neida Conrad
VZVitória Sequeira Gonçalves Zorzi
Vitória Sequeira Gonçalves Zorzi
Ana Vitória Costa¹Ana Vitória Costa¹
Ana Vitória Costa¹
PRPaulo Ricardo Centeno Rodrigues
Paulo Ricardo Centeno Rodrigues
FLFabio Leite
Fabio Leite
Bacillus toyonensis is a spore-forming bacterium widely used as a probiotic for animals and humans. It has been reported for its immunomodulatory properties, particularly in enhancing innate and acquired immune responses. One mechanism involved in immune modulation is the capacity of B. toyonensis to stimulate immune cells to produce cytokines. This study investigated the immunomodulatory effects of Bacillus toyonensis BCT-7112T on the macrophage-like cell line RAW 264.7. Cells were stimulated with B. toyonensis vegetative cells (live and killed), spores (viable and non-viable), DNA, and conditioned media for 24, 48, and 72 hours to evaluate proliferation. Additionally, cells were stimulated for 1, 8, and 24 hours and analyzed by qPCR for the transcription of Tnf-α, Il4, Il10, Nuclear Factor kappa Beta (Nfkβ), and Toll-like receptor 2 (Tlr-2). All B. toyonensis stimuli induced cell proliferation, with spores exhibiting the most significant increase (p < 0.05) across all time points. B. toyonensis also induced the transcription of Tnf-α, Il4, Il10 cytokines, Nfkβ, and Tlr-2, with the most pronounced effects (p<0.05) observed following stimulation with viable spores. Our findings suggest that B. toyonensis BCT-7112T has immunomodulatory effects through the activation of murine RAW 264.7 cells, supporting its potential as a model for studying probiotic immunomodulation.